HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Z-360

an orally-active CCK-2R antagonist for treatment of gastrointestinal cancer models; structure in first source
Also Known As:
calcium bis((R)-(-)-3-(3-(5-cyclohexyl-1-(3,3-dimethyl-2-oxo-butyl)-2-oxo-2,3,4,5-tetrahydro-1H-benzo(b)(1,4)diazepin-3-yl)ureido)benzoate)
Networked: 8 relevant articles (2 outcomes, 4 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Yoshinaga, Koji: 5 articles (10/2011 - 04/2008)
2. Takei, Mineo: 5 articles (10/2011 - 04/2008)
3. Seto, Koichi: 4 articles (10/2011 - 01/2010)
4. Hamano, Hiroki: 4 articles (01/2010 - 04/2008)
5. Kobayashi, Nobuyoshi: 3 articles (10/2011 - 01/2010)
6. Orikawa, Yuki: 3 articles (01/2010 - 01/2010)
7. Kato, Hiroki: 2 articles (10/2011 - 01/2010)
8. Meyer, Tim: 2 articles (10/2011 - 01/2010)
9. Hori, Yuko: 2 articles (01/2010 - 01/2010)
10. Eta, Runa: 2 articles (01/2010 - 04/2008)

Related Diseases

1. Pain (Aches)
2. Pancreatic Neoplasms (Pancreatic Cancer)
3. Neoplasms (Cancer)
4. Carcinoma (Carcinomatosis)
5. Adenocarcinoma

Related Drugs and Biologics

1. Ephrin-B1 (Ephrin B1)
2. Interleukin-1 (Interleukin 1)
3. gemcitabine
4. Cholecystokinin B Receptor
5. Gastrins
6. Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
7. Carbon Monoxide
8. Opioid Analgesics (Opioids)
9. Analgesics (Analgesic Drugs)
10. Cholecystokinin (Pancreozymin)

Related Therapies and Procedures

1. Heterologous Transplantation (Xenotransplantation)
2. Stents
3. Oral Administration